ZAMONAVIY TURMUSH TARZI VA 2-TIP QANDLI DIABET RIVOJLANISHI: EPIDEMIOLOGIK TAHLIL
Abstract
Kirish. Ushbu tadqiqot O‘zbekistonda zamonaviy turmush tarzi omillari, jumladan, kamharakatlik, noto‘g‘ri ovqatlanish va stressning 2-tip qandli diabet (2-TQD) rivojlanishiga ta’sirini epidemiologik jihatdan o‘rganishga qaratilgan. So‘nggi yillarda mamlakatda bu kasallikning tarqalishi keskin oshgan bo‘lib, bu shaharlashtirish va texnologiyalarning jadal rivoji bilan bog‘liq. Tadqiqot kasallikning erta bosqichdagi belgilari va profilaktika choralarini baholashni maqsad qiladi.
References
1. International Diabetes Federation. IDF Diabetes Atlas. 11th edition. Brussels: International Diabetes Federation; 2025. (Mualliflar guruhi: Dianna J. Magliano, Edward J. Boyko, Irini Genitsaridi, Lorenzo Piemonte, Phil Riley, Paraskevi Salpea va boshqalar).
2. Genitsaridi I, Magliano DJ, Boyko EJ, va boshqalar. 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. The Lancet Diabetes & Endocrinology. 2025; (yoki 2026 nashrida e'lon qilingan maqola).
3. Ziyadullaev S, Eshmuradova S, Kadirov J, Saidov M, Ruzimurodov N, Nazirkulov O. Central obesity and glycaemic control in newly diagnosed type 2 diabetes mellitus patients: evidence from Uzbekistan. BMC Endocrine Disorders. 2026;26:66. doi:10.1186/s12902-026-02187-0.
4. Alieva A, Alimov A, Khaidarova F, Ismailov S, Rakhimova G, Nazhmutdinova D, Shagazatova B, Tsareva V. Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan. International Journal of Endocrinology and Metabolism. 2022;20(4):e124036. doi:10.5812/ijem-124036.
5. Alieva AV, Ismailov SI, Rakhimova GN. Epidemiology of Diabetes and Prediabetes in Uzbekistan: Screening Results. Journal of Diabetes & Metabolism. 2018; (yoki shunga o'xshash nashr).
6. Ibragimova N, Tregulova R, Normatova N, Djalalov S. Comparative analysis of the prevalence of type 2 diabetes according to the screening and register data in Uzbekistan. Endocrine Abstracts. 2018;56:P342.
7. Abdubannonovna XG (Xodjayeva Gulnora Abdubannonovna). Diabetes mellitus in Uzbekistan: prevalence and medical responses. Continuing Education: International Experience, Innovation, and Transformation. 2025.
8. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis. The Lancet. 2024.
9. Zakirova D, va boshqalar. Polymorphic variants in DOCK7, ABCG8, UBE2E2, and SYN2 genes associated with type 2 diabetes in the Uzbek population. PubMed / tegishli jurnal. 2025.
10. Lin L, va boshqalar. Burden of type 2 diabetes mellitus and risk factor attribution among older adults: A global, regional, and national analysis from 1990 to 2021, with projections up to 2040. Diabetes, Obesity and Metabolism. 2025.
11. Alieva AV, Ismailov SI, Rakhimova GN. The most significant risk factors for type 2 diabetes in Uzbek population. Endocrinology & Diabetes Research. 2018;4:65.
12. Rakhimova N, Akhmedov S, Mavlonov M. Prevalence and risk factors of type 2 diabetes in Uzbekistan: population-based analysis. Uzbek Medical Journal. 2025 (yoki shunga o'xshash).
13. King H, va boshqalar. Epidemiology of glucose intolerance and associated factors in Uzbekistan: a survey in Sirdaria province. Diabetes Research and Clinical Practice. 2002;55(1):19-27.
